Share:

Life Sciences: COVID-19 Report

Kenneth McCarthy • 6/26/2020

Life sciences covid-19 (image)

The life sciences sector holds a unique place in the disruptive new landscape resulting from COVID-19. Like most businesses, it has been negatively impacted by the lockdowns, but it is also the sector expected to produce a vaccine or treatment that will mitigate the pandemic. 12 featured local market snapshots give an overview into the life sciences sector and the impact of the pandemic, establishing a baseline for analyzing potential impact in the months to come. 

The Life Sciences: COVID-19 Report explores the life science industry's unique position in the COVID-19 landscape, including: 

  • Pre-pandemic situation 
  • Sector employment trends 
  • Fight against the virus
  • Financial performance and real estate implications
  • Key market highlights  

Download the report to learn more.

 

Insights in your inbox
Subscribe to get Cushman & Wakefield's latest Recovery Readiness updates and insights. We also look forward to hearing from you to see how we can help.
Subscribe Contact us today

Related Insights

2020 Life Science Report
Research • Medical

Life Sciences 2020: The Future is Here

Innovative technologies and aging demographics are driving a wave of demand for R&D space, diagnostic centers and healthcare facilities.
2/5/2020
life sciences infographic card
Research • Medical

Synthesizing Life Sciences Trends

The life science industry is one of the fastest-growing sectors in the U.S. economy, with many recession-resistant characteristics. Cushman & Wakefield has synthesized the latest trends in this dynamic sector.
Greg Bisconti • 12/5/2019
healthcare
Research • Healthcare

Healthcare and Medical Office Fall Report

Cushman & Wakefield's Vital Signs Healthcare and Medical Office Fall report covers the sector's positive outlook and growth.
Lorie Damon • 11/21/2019